Attività
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Commercial and Other
82,6
%
| 54 | 81,6 % | 52 | 82,6 % | -4,06% |
National Institutes of Health
17,4
%
| 12 | 18,4 % | 11 | 17,4 % | -10,64% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 66 | 100,0 % | 63 | 100,0 % | -5,27% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Mark G. Lewis
CEO | Chief Executive Officer | 69 | 01/08/03 |
Charles C Kirk
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | - | 09/05/22 | |
Chief Operating Officer | - | - | |
Nancy A. Madden
ADM | Chief Administrative Officer | - | 01/01/03 |
Chander P. Sarma
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/94 |
Director/Board Member | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Director/Board Member | 87 | 01/01/15 | |
Mark G. Lewis
CEO | Chief Executive Officer | 69 | 01/08/03 |
Director/Board Member | - | - | |
David B. Landon
BRD | Director/Board Member | 61 | 19/04/17 |
Director/Board Member | 86 | 01/01/91 | |
Director/Board Member | 68 | 01/01/92 | |
Director/Board Member | 48 | 25/07/18 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 1 599 408 | 894 416 ( 55,92 %) | 704 992 ( 44,08 %) | 55,92 % |
Coordinate società
Settore
Vendite per attività
Variaz. 1 gen. | Capi. | |
---|---|---|
+43,36% | 54,64 Mrd | |
-5,31% | 39,92 Mrd | |
+37,52% | 38,82 Mrd | |
+14,75% | 26,86 Mrd | |
-12,56% | 26,22 Mrd | |
-22,45% | 18,78 Mrd | |
+0,04% | 12,16 Mrd | |
+25,12% | 12,21 Mrd | |
+26,04% | 11,94 Mrd |